The phrase "a later issue of" is correct and usable in written English.
It can be used when referring to a subsequent edition or version of a publication, such as a magazine, journal, or newsletter.
Example: "The article was published in a later issue of the magazine, providing updated information on the topic."
Alternatives: "a subsequent edition of" or "a following release of".
The full interview is to appear in a later issue of the magazine, but here are some snippets.
Their attack was controversial, to say the least, and there were outraged responses in a later issue of that journal, including one with 137 authors.
Under the language of this clause a publishing company could reprint a contribution from one issue in a later issue of its magazine, and could reprint an article from a 1980 edition of an encyclopedia in a 1990 revision of it; the publisher could not revise the contribution itself or include it in a new anthology or an entirely different magazine or other collective work.
In a later issue of Health Affairs, Senator Brownback wrote, "After reading their proposal in Health Affairs, I met with Ridley and colleagues to discuss the idea further, and I subsequently drafted an amendment... Indeed, their idea is the heart of my Elimination of Neglected Diseases (END) amendment" (Brownback 2007).
Five albums to which he contributed were included in Rolling Stone Indonesia list of the 150 Best Indonesian Albums of All Time; another four of his songs (and a fifth to which he contributed) were classified as some of the best Indonesian songs of all time in a later issue of the same magazine.
In a later issue of Critical Care, Rajendran and Hutchinson [ 2] suggested the use of a checklist, adapted from the World Health Organization (WHO) surgical safety checklist, to improve safety and reduce errors and harm related to the PT procedure in critical care.
In a later issue, a couple of tribesmen responded from Danbury, Connecticut: "We absolutely, positively agree that rock 'n' roll has to be here to stay.
Before this, but receiving little attention, a suggestion appeared that rosiglitazone was associated with an adverse cardiovascular (CV) profile specifically in regard to myocardial ischemia, this becoming a headline issue after a later publication of an integrated trial-level analysis in New England Journal of Medicine (4, 6) and resulting in a further regulatory review in the summer of 2010.
Later issues of the journal carried a disclaimer that the publication primarily contained company-sponsored articles, Merck said.
The refunding of all the old issues of bonds by the issuance of the constitutional 4s paved the way for later issues of other classes of bonds.
